Health Care

New insider buying of IRIDEX shows growing confidence: Novel Inspiration’s steady buildup amid a 45% monthly rally suggests potential upside for value investors.

Insight: Nano‑X’s insider RSU buys signal management confidence amid an 88% stock decline – understand the timing, vesting risks, and potential rally triggers.

Insider buying surges at Adagio Medical Holdings, signaling confidence in its ablation tech and upcoming product launches.

CEO Nassif Mikheal’s recent 505‑share buy at $11.95 shows quiet confidence in Neogen’s growth, hinting that insiders see value amid rising revenue and a tighter loss.

Pacira BioSciences insider trade: Riker Lauren buys 6,000 shares at $32.35 and sells 6,000 at $36.32 amid Viatris acquisition, signaling confidence in future growth.

Maravai CEO’s latest insider sale shows a “portfolio‑manager” pattern—selling $5.70 avg while still holding 25% stake, hinting at confidence despite market dips.

Immunovant insider sales reveal routine tax‑cover moves, not a sell‑off warning—track RSU patterns and Phase III data for investment insights.

Insider selling by BIONTECH SE CEO Sahin Ugur hits $27 M—high volume but low impact, signaling routine liquidity, not imminent distress.

Insider buy at a discount signals Martine Rothblatt’s confidence in United Therapeutics’ pipeline and long‑term upside, a bullish sign for investors.

CEO Jason Matuszewski’s $0.5 M share buy signals confidence in BioStem Technologies amid a 40% stock decline, but investors must weigh weak fundamentals and regulatory risk.